NeuroKaire
PrivateLast Round
Early Funding
Dec 17, 2024
Total Funding Raised
$39.85M
Company Overview
NeuroKaire is a biotechnology company that provides a personalized medical testing tool to help physicians find the best drug therapy for patients with psychiatric and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Mental Health, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroKaire Comps
Public and private peers based on sector, stage, and business model.
NeuroKaire Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 17, 2024 | ||||
| Grant | Jul 26, 2022 | ||||
| Series A | Sep 30, 2021 | ||||
| Seed | May 1, 2019 | ||||
| Accelerator | Nov 6, 2018 |
NeuroKaire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Israel Innovation Authority | Seed |
| MassChallenge | Accelerator |
| Meron Capital | Series A, Seed, Early Funding |
| Jumpspeed Ventures | Series A, Seed, Early Funding |
| Sapir Venture Partners | Series A, Seed, Accelerator |
| GreyBird Ventures | Series A, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Partnered with Compass Pathways for precision psychiatry and neurology research.
- Jan 1, 2025
Received Best Pitch Award at HealthTech Investment Days.
NeuroKaire Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroKaire's valuation, stock price, and market status.
